The Medicare GLP-1 Bridge vs. Private Insurance: A Coverage Comparison
The Bridge covers brand-name Wegovy and Zepbound through Part D with a December 2027 sunset. How it compares to Medicare Advantage formularies and cash-pay for Medicare-eligible patients.
If you're Medicare-eligible and considering GLP-1 treatment, you now have a choice: the new CMS GLP-1 Bridge demonstration (launched July 1, 2026) or your private insurance if you have supplemental coverage. Here's the comparison that helps you decide which pathway to pursue.
Medicare GLP-1 Bridge in detail
The Bridge is a Part D program — it covers Wegovy and Zepbound at obesity doses through your existing Part D plan. Cost-sharing: standard Part D cost-sharing applies until you hit the $2,000 annual out-of-pocket cap (per the Inflation Reduction Act), after which your out-of-pocket drops to zero. For low-income subsidy (LIS) beneficiaries, cost-sharing is minimal from the first fill.
The Bridge expires December 31, 2027. Patients who start treatment and respond well face coverage loss at the sunset date unless Congress acts or CMS extends the demonstration. The long-term discontinuation data (SURMOUNT-4, STEP-1 extension) shows significant weight regain after stopping — making a two-year coverage window with an uncertain renewal a real clinical planning issue.
Private insurance coverage (Medigap + Medicare Advantage)
Medicare Advantage (Part C) plans may offer more comprehensive GLP-1 coverage than Original Medicare — some plans include obesity drug coverage beyond the Bridge. If you have Medicare Advantage, check your plan's formulary specifically for Wegovy and Zepbound at obesity doses. Medigap supplemental policies don't typically add drug coverage beyond Part D.
Comparison table
| Factor | GLP-1 Bridge (Part D) | Medicare Advantage | Cash-pay telehealth |
|---|---|---|---|
| Covered drugs | Wegovy, Zepbound (brand only) | Plan-specific formulary | Any (branded or compounded) |
| Cost structure | Standard Part D + $2K cap | Plan-specific copay | $150–500/month cash |
| Prior authorization | Required | Required | None (telehealth only) |
| Sunset risk | Dec 31, 2027 | Annual renewal | None (regulatory risk to supply) |
Verified telehealth providers
Medicare-compatible visits. Prescribers who can submit Bridge PA. Brand-name prescriptions.
Paid link Get started →Works with insurance and cash-pay — can navigate the Bridge or provide cash-pay alternative.
Paid link Get started →